Sellas Life Sciences Group Inc.
Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]
Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]
Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]
01/20/2022 | Press release | Distributed by Public on 01/20/2022 07:40
Please select the service you want to use:
Smartlinks | Datto Holding Corp. | News | Technology | Internet | Local News | Politics and Policy | Policy and Regulation | Data Protection and Privacy | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Mergers and Acquisitions | Business Announcement | Products and Services | Financial Services | Investment Funds | Investment Services | Information Technology | Software | IT Security | Public Companies | Software Companies | New York Stock Exchange (NYSE) | NYSE American | NYSE ARCA Equities | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact